Research · Randomized controlled trial
A Randomized Trial of Silymarin for the Treatment of Nonalcoholic Steatohepatitis
What it found
Did not significantly meet the histologic fibrosis endpoint; may modestly improve liver enzymes.
- Design
- Randomized controlled trial
- Year
- 2017
- Population
- adults with biopsy-proven NASH
- Intervention
- silymarin (milk thistle)
- Outcome
- liver histology / enzymes
- Journal
- Clinical Gastroenterology and Hepatology
Citation last checked 2026-06-21.